Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Early-onset bipolar spectrum disorders: diagnostic issuesDSM-5: disruptive mood dysregulation disorderDisruptive mood dysregulation disorder: current insightsGenome-wide association study of the child behavior checklist dysregulation profileSafety of stimulant treatment in attention deficit hyperactivity disorder: part II.Adult outcomes of childhood dysregulation: a 14-year follow-up studyPsychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder.A novel group therapy for children with ADHD and severe mood dysregulation.A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).Assessment of dysregulated children using the Child Behavior Checklist: a receiver operating characteristic curve analysis.Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.Bipolar and ADHD Comorbidity: Both Artifact and Outgrowth of Shared MechanismsPhenomenology and diagnosis of bipolar disorder in children, adolescents, and adults: complexities and developmental issues.Childhood CBCL bipolar profile and adolescent/young adult personality disorders: a 9-year follow-up.Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA).Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorderThe safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.Early onset bipolar disorder: clinical and research considerations.Prepubertal bipolar disorder: available pharmacological treatment options.Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycle.Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology.Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis.Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.Mood regulation in youth: research findings and clinical approaches to irritability and short-lived episodes of mania-like symptoms.Pharmacotherapeutic strategies for pediatric bipolar disorder.The 24-month course of manic symptoms in childrenThe efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation.Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people.Attention deficit-hyperactivity disorder and early-onset bipolar disorder: two facets of one entity?Antidepressants and psychostimulants in pediatric populations: is there an association with mania?The comorbidity of ADHD and bipolar disorder: any less confusion?ADHD and Emotion Dysregulation Among Children and Adolescents.Evidence-based treatments for youths with severely dysregulated mood: a qualitative systematic review of trials for SMD and DMDD.Dysregulation in Youth with Anxiety Disorders: Relationship to Acute and 7- to 19- Year Follow-Up Outcomes of Cognitive-Behavioral Therapy.Deciding on stimulant use for childhood ADHD: maintaining focus on the key questions.Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents.The child behavior checklist dysregulation profile predicts adolescent DSM-5 pathological personality traits 4 years later.Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.
P2860
Q22061981-EADF582D-919A-47FC-A4A5-93CB8DCD152DQ24619731-715EC503-ED82-40EA-8D13-9D55B4A58C7AQ26853229-331F65C4-DBE6-43E2-B88C-EC19B87E021DQ28069569-E2D171DC-C619-4C6B-A8E0-036FE5D3040CQ28943428-AF574381-280B-4E40-9AEE-866C741C444EQ30451303-54995F1E-8016-41F9-88B3-40AC99D7AADCQ30497165-1101ED18-67D5-4F68-BE92-92A7AC5F9038Q33714517-3473A401-39AE-4CD6-A3EB-33C7BA4D4CD6Q33820624-A2BE31DE-ACE3-430B-AA81-7AA559843BBDQ33925017-9B04C051-01A0-4697-8310-F50E16A06758Q34116144-75D6A681-A3DE-44C7-AF05-66147121A4C5Q34152823-F04BE067-3706-42FB-A4CC-C58FA16E4633Q34526592-E1A663A1-1660-4164-8156-4AF51F85A76BQ34572065-92378D33-F5CB-4495-AE38-FFEE39C974E7Q34687428-91479D06-6BC7-413F-B7EB-07E27436E46DQ34826806-ED6FFB8A-196F-41B4-8983-EADA238A24DBQ35486056-8BAAF90F-9D8A-4C9A-BC10-125B0253F2F7Q36082025-FC3F3BC8-30C8-4158-8EE3-51DC18EEF5E9Q36131344-640CC4F5-F75B-48C9-B8E8-5AAD7F675A2BQ36150677-6D2E1811-9393-4978-A669-71F4B545F589Q36634409-C86A90BA-E535-4B0D-8016-68BA09B454DDQ36648476-ACE15B22-3679-4C7B-9AB6-CB8E97CB3860Q36687442-419DC348-F872-4F2B-9DA8-907742779821Q36693361-75DC29BF-D8FF-468C-AA87-48DC1A423F6BQ36765769-31E89CD1-65A7-429B-9C2E-5E364C3B203FQ36864683-3DFD2185-F775-49AD-9D16-A0D1170EACBCQ36909255-825EE870-C778-4D0F-8B61-52C1BC724A22Q37146741-46D5E03F-6DB6-46D7-87AC-03681BB6C132Q37186841-075B0662-D1A5-4A64-9F57-7C9A41E0D13CQ37355406-F5E9088E-CF83-443E-936E-AC11C8A3542CQ37477118-A544CDA4-8A29-47CA-9A9B-743DC3FFE2C4Q37892521-D64A6AA8-167D-4C69-A182-64FD7C1A1224Q38109854-AA8A9503-0FCF-40E4-AF1F-0AC01E50D16EQ38561013-93242F21-48BB-46D0-B4EF-8670C78A5933Q38818252-B911E01B-C857-4B3E-A8F4-797E27E88812Q39187211-45EE750F-3EBA-439A-A296-C12B1629D7FDQ42983372-25F1E18A-7E51-4A59-AC5F-5F8384D61B32Q43660474-BDFA5640-EE6C-449D-96FE-A478AD71615FQ43844145-98BEF5D0-A51D-47C0-9526-BA9928582DACQ44374420-758061E4-2DA7-4807-8589-CA23DEF073AF
P2860
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Response to methylphenidate in ...... vity disorder titration trial.
@en
Response to methylphenidate in ...... vity disorder titration trial.
@nl
type
label
Response to methylphenidate in ...... vity disorder titration trial.
@en
Response to methylphenidate in ...... vity disorder titration trial.
@nl
prefLabel
Response to methylphenidate in ...... vity disorder titration trial.
@en
Response to methylphenidate in ...... vity disorder titration trial.
@nl
P2093
P1476
Response to methylphenidate in ...... vity disorder titration trial.
@en
P2093
Cathryn A Galanter
Gabrielle A Carlson
Glen R Elliott
James M Swanson
John S March
L Eugene Arnold
Laurence L Greenhill
Lily Hechtman
Mark Davies
Peter S Jensen
P304
P356
10.1089/104454603322163844
P577
2003-01-01T00:00:00Z